Significantly reduces Alzheimer and dementia.
69% decrease over 7 years.
newsroom.clevelandclinic.org
69% decrease over 7 years.
Cleveland Clinic Research Identifies Sildenafil as Candidate Drug for Alzheimer’s Disease
A new Cleveland Clinic-led study has identified sildenafil – an FDA-approved therapy for erectile dysfunction (Viagra) and pulmonary hypertension (Revatio) – as a promising drug candidate to help prevent and treat Alzheimer’s disease. According to findings published in Nature Aging, the research...
newsroom.clevelandclinic.org
